Discovery Early Career Researcher Award - Grant ID: DE180100484
Funder
Australian Research Council
Funding Amount
$365,058.00
Summary
Tipping the balance from tolerance to immunity for the devil facial tumour. This project aims to develop a single-shot vaccine for the Tasmanian devil facial tumour disease. The disease is an enigma because the transmissible tumours are simultaneously cancer, infections, and genetically mismatched tissue grafts. This project will focus on immune molecules that are revolutionising human oncology, and will develop techniques to understand and systematically test the function of these key molecules ....Tipping the balance from tolerance to immunity for the devil facial tumour. This project aims to develop a single-shot vaccine for the Tasmanian devil facial tumour disease. The disease is an enigma because the transmissible tumours are simultaneously cancer, infections, and genetically mismatched tissue grafts. This project will focus on immune molecules that are revolutionising human oncology, and will develop techniques to understand and systematically test the function of these key molecules in Tasmanian devils. Understanding the role of these immune molecules will accelerate development of a vaccine to help save the devil and has the potential to shed light on general principles relating to how the immune system balances tolerance and immunity.Read moreRead less
Immunisation to protect against transmissible cancers in Tasmanian devils. This project aims to identify the immune escape mechanisms that the transmissible cancers, Devil Facial Tumour Disease (DFTD) use to avoid being killed by the immune system. Since the discovery of the second transmissible cancer (DFT2) mystery surrounds whether the devils immune system can respond to this cancer, hence this project will investigate the immune response to DFT2. The final aims are to develop a vaccine with ....Immunisation to protect against transmissible cancers in Tasmanian devils. This project aims to identify the immune escape mechanisms that the transmissible cancers, Devil Facial Tumour Disease (DFTD) use to avoid being killed by the immune system. Since the discovery of the second transmissible cancer (DFT2) mystery surrounds whether the devils immune system can respond to this cancer, hence this project will investigate the immune response to DFT2. The final aims are to develop a vaccine with the potential to protect healthy devils and cure devils with DFTD.Read moreRead less
Host-tumour interplay in Tasmanian devils with devil facial tumour disease: can immune cells be harnessed for therapy? Tasmanian devils only exist naturally in Tasmania and Devil Facial Tumour Disease, an infectious cancer, could cause the extinction of the Tasmanian devil. This project will determine if Devil Facial Tumour Disease reduces the effectiveness of the devil's immune system and test if activated immune cells can protect against this disease.
Evaluating host-parasite interplay in individual tissues. The immune system of the host and the infecting parasite has coevolved into a sophisticated balance of power. This project will explore this balance using Schistosoma japonicum infection in sheep and determine immune mechanisms unleashed by the host in various tissues as well as the response of the parasite to these attacks.
Immunonutrition: A novel concept to overcome gastrointestinal tract mucosal damage after weaning in pigs. A sustainable Australian pork industry relies on further reductions in costs whilst considering the enhanced health and welfare of pigs. This project will lead to more precise estimates of amino acid requirements in the post-weaning period, which will contribute to an increased efficiency of nutrient utilization and enhance the welfare of pigs recovering from the weaning process.
Linking immunomodulation and latency in alphaherpesvirus infection. Herpesviruses cause major diseases in humans and all domestic animal species. Latency forms a significant part of the evolutionary success of herpesviruses, by enabling transmission of the virus throughout the lifetime of the host. Our work has shown that an alphaherpesvirus protein can divert the host’s immune response to become more antibody-mediated and less T cell-mediated. This study explores the consequences of this immune ....Linking immunomodulation and latency in alphaherpesvirus infection. Herpesviruses cause major diseases in humans and all domestic animal species. Latency forms a significant part of the evolutionary success of herpesviruses, by enabling transmission of the virus throughout the lifetime of the host. Our work has shown that an alphaherpesvirus protein can divert the host’s immune response to become more antibody-mediated and less T cell-mediated. This study explores the consequences of this immune diversion, and examines whether this reduced T cell response enables the development of latent infections. Disrupting the virus-host balance by alterations to this conserved viral protein will enable novel approaches to controlling these economically significant viruses.Read moreRead less
Development of an amoebic gill disease vaccine to protect Atlantic salmon. This project aims to identify candidate vaccine antigens and produce an experimental vaccine against amoebic gill disease (AGD) that will benefit the Tasmanian and international Atlantic salmon aquaculture industries. AGD is the most significant health problem affecting Atlantic salmon aquaculture in Tasmania. In the last decade, AGD has become a legitimate health threat to the multibillion dollar global Atlantic salmon i ....Development of an amoebic gill disease vaccine to protect Atlantic salmon. This project aims to identify candidate vaccine antigens and produce an experimental vaccine against amoebic gill disease (AGD) that will benefit the Tasmanian and international Atlantic salmon aquaculture industries. AGD is the most significant health problem affecting Atlantic salmon aquaculture in Tasmania. In the last decade, AGD has become a legitimate health threat to the multibillion dollar global Atlantic salmon industry. A solution is needed before AGD fully establishes itself in the largest Atlantic salmon producing nations. The expected outcome of this project is the development of a commercial vaccine that should significantly benefit the Australian and international aquaculture industries. Read moreRead less
Development of an immune enhancing vaccine to protect Tasmanian devils against a contagious cancer. The iconic Tasmanian devil is threatened with extinction from a uniformly fatal transmissible facial cancer. Our team has shown in proof of concept that the cancer cells can be recognised by the devil immune system. This project will develop and test a vaccine against the tumour, which will ultimately protect devils in the wild.
Development of a safe and immunogenic anti-chlamydia vaccine for the koala. Many koala populations are under threat of extinction from chlamydial disease.The project will develop a chlamydial vaccine and conduct trials in several wild koala populations for safety and effectiveness.
Understanding gender differences in pain: Cellular therapies for animal pain. Understanding gender differences in pain: Cellular therapies for animal pain. This project aims to relieve chronic pain in animals and lay the foundations for future human therapies, using molecular assays, cell technologies and immune/hormonal pain generators. Chronic pain affects females more than males. Establishing the fundamental mechanism in pain, the role of immune signalling and molecular mediators will enable ....Understanding gender differences in pain: Cellular therapies for animal pain. Understanding gender differences in pain: Cellular therapies for animal pain. This project aims to relieve chronic pain in animals and lay the foundations for future human therapies, using molecular assays, cell technologies and immune/hormonal pain generators. Chronic pain affects females more than males. Establishing the fundamental mechanism in pain, the role of immune signalling and molecular mediators will enable true pain-modifying treatments that address pivotal triggers in both genders. This project will then use specially selected stem cells separately targeting arthritic male and female pain and demonstrate novel veterinary chronic pain treatments. Expected outcomes are more effective gender-targeted treatments of pain and the realisation of economic value of molecular assays and cell technologies.Read moreRead less